Enterococcus faecium

cellular organisms|Bacteria|Bacillati|Bacillota|Bacilli|Lactobacillales|Enterococcaceae|Enterococcus
Synonyms: Streptococcus faecium
MCA-BAC-000052
TaxID: 1352 | BacDive: 5295 | Rank: species
Biology & Ecology
Biology
Gram Statusgram-positive
Oxygen Tolerancefacultative anaerobe
Morphologycoccus
Ecology
Primary Nichesgut
Reservoirfood, human
Metabolites

No metabolite relationships documented for this taxon.

Clinical Profile
Pathobiont
yes no context dependent unknown
Clinical Rolescommensal
Typical Specimenstool
Risk Contextsmelanoma patients receiving immune checkpoint inhibitor therapy (ICB)
Clinical Associations:
E2
E3 — Strong human clinical evidence E2 — Moderate human evidence E1 — Limited / preliminary
Enterococcus faecium was among 8 commensal species significantly enriched in pre-treatment stool of metastatic melanoma anti-PD-1 responders (n=16) versus non-responders (n=26) by integrated 16S rRNA, shotgun metagenomic, and qPCR analysis (P<0.05, permutation test); it was highlighted in the abstract as one of three key responder-enriched species and was part of a 10-species composite qPCR score significantly higher in responders (P=0.004).
PMID: 29302014
D016984 Enterococcus faecium D007167 Immunotherapy D008545 Melanoma D061026 Programmed Cell Death 1 Receptor H00038 Melanoma
Last reviewed: 2026-04-03
Evidence Timeline
Related Taxa Shared Niche = same body site   Shared Risk = same vulnerable population